BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33781747)

  • 1. Overexpression of hepatic serum amyloid A1 in mice increases IL-17-producing innate immune cells and decreases bone density.
    Choi M; Park S; Yi JK; Kwon W; Jang S; Kim SY; Yu W; Kim MO; Ryoo ZY; Choi SK
    J Biol Chem; 2021; 296():100595. PubMed ID: 33781747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic serum amyloid A1 upregulates interleukin-17 (IL-17) in γδ T cells through Toll-like receptor 2 and is associated with psoriatic symptoms in transgenic mice.
    Choi M; Kim MO; Lee J; Jeong J; Sung Y; Park S; Kwon W; Jang S; Park SJ; Kim HS; Jang WY; Kim SH; Lee S; Choi SK; Ryoo ZY
    Scand J Immunol; 2019 Jun; 89(6):e12764. PubMed ID: 30892738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid A promotes lung neutrophilia by increasing IL-17A levels in the mucosa and γδ T cells.
    Anthony D; Seow HJ; Uddin M; Thompson M; Dousha L; Vlahos R; Irving LB; Levy BD; Anderson GP; Bozinovski S
    Am J Respir Crit Care Med; 2013 Jul; 188(2):179-86. PubMed ID: 23627303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice.
    Ji YR; Kim HJ; Bae KB; Lee S; Kim MO; Ryoo ZY
    J Biol Chem; 2015 May; 290(20):12804-11. PubMed ID: 25847238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts.
    Choudhary S; Goetjen A; Estus T; Jacome-Galarza CE; Aguila HL; Lorenzo J; Pilbeam C
    J Biol Chem; 2016 Feb; 291(8):3882-94. PubMed ID: 26703472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
    Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
    PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice.
    Singh K; Piprode V; Mhaske ST; Barhanpurkar-Naik A; Wani MR
    J Immunol; 2018 Jan; 200(2):595-606. PubMed ID: 29203513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
    Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
    Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid A1 levels and amyloid deposition following a high-fat diet challenge in transgenic mice overexpressing hepatic serum amyloid A1.
    Jang WY; Jeong J; Kim S; Kang MC; Sung YH; Choi M; Park SJ; Kim MO; Kim SH; Ryoo ZY
    Appl Physiol Nutr Metab; 2016 Jun; 41(6):640-8. PubMed ID: 27218680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of RANKL by peripheral neutrophils and its association with bone mineral density in COPD.
    Hu X; Sun Y; Xu W; Lin T; Zeng H
    Respirology; 2017 Jan; 22(1):126-132. PubMed ID: 27552066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of serum amyloid a 1 induces depressive-like behavior in mice.
    Jang WY; Lee BR; Jeong J; Sung Y; Choi M; Song P; Kim H; Jang S; Kim H; Joo KI; Lee JW; Choo YS; Kim E; Ryoo ZY
    Brain Res; 2017 Jan; 1654(Pt A):55-65. PubMed ID: 27608955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation.
    Shridas P; De Beer MC; Webb NR
    J Biol Chem; 2018 Aug; 293(34):13257-13269. PubMed ID: 29976759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J; Jing Z; Hu W; Yu J; Cui X
    Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
    Romas E; Gillespie MT; Martin TJ
    Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
    Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R.
    He R; Sang H; Ye RD
    Blood; 2003 Feb; 101(4):1572-81. PubMed ID: 12393391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid A inhibits osteoclast differentiation to maintain macrophage function.
    Kim J; Yang J; Park OJ; Kang SS; Yun CH; Han SH
    J Leukoc Biol; 2016 Apr; 99(4):595-603. PubMed ID: 26538527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
    Suda K; Udagawa N; Sato N; Takami M; Itoh K; Woo JT; Takahashi N; Nagai K
    J Immunol; 2004 Feb; 172(4):2504-10. PubMed ID: 14764723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.